Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.
|
1 |
Autio A et al. |
Preclinical evaluation of a radioiodinated fully human antibody for in vivo imaging of vascular adhesion protein-1-positive vasculature in inflammation.
|
|
2 |
Avoranta ST et al. |
ALDH1 expression indicates chemotherapy resistance and poor outcome in node-negative rectal cancer.
|
|
3 |
Avoranta T. |
The Prognostic and Predictive Value of Selected Biomarkers in Colorectal Cancer.
|
|
4 |
Benberin V et al. |
Prevalence of H. pylori infection and atrophic gastritis among symptomatic and dyspeptic adults in Kazakhstan. A hospital-based screening study using a panel of serum biomarkers.
|
|
5 |
Coleman R et al. |
Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results.
|
|
6 |
Elme A et al. |
Obesity and physical inactivity are related to impaired physical health of breast cancer survivors.
|
|
7 |
Elzagheid A et al. |
High cyclooxygenase-2 expression is associated with advanced stages in colorectal cancer.
|
|
8 |
Elzagheid A et al. |
Loss of MUC2 expression predicts disease recurrence and poor outcome in colorectal carcinoma.
|
|
9 |
Ermiah E. |
Libyan breast cancer: Health services and biology. Diagnosis delay and prognostic value of DNAploidy, S-phase fraction, and Ki-67 and Bcl-2 immunohistochemistry.
|
|
10 |
Ermiah E et al. |
Prognostic value of bcl-2 expression among women with breast cancer in Libya.
|
|
11 |
Heiskanen T et al. |
Kipu palliatiivisessa hoidossa.
|
|
12 |
Holte H et al. |
Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study.
|
|
13 |
Jaakkola PM, Rantanen K. |
The regulation, localization, and functions of oxygen-sensing prolyl hydroxylase PHD3.
|
|
14 |
Joensuu H et al. |
Syöpätaudit. 5., uudistettu painos.
|
|
15 |
Kalhori V et al. |
Sphingosine-1-phosphate as a regulator of hypoxia-induced factor-1a in thyroid follicular carcinoma cells.
|
|
16 |
Kauhanen S et al. |
Positroniemissiotomografian ja magneettikuvauksen yhdistelmällä tarkkuutta onkologiseen kuvantamiseen?
|
|
17 |
Kellokumpu-Lehtinen PL et al. |
2-weekly versus 3-weekly docetaxel to treat castration-resistant advanced prostate cancer: a randomised, phase 3 trial.
|
|
18 |
Kero K et al. |
Reply to Kathleen D'Hauwers, Gunter De Win and Wiebren Tjalma's letter to the editor re: Katja Kero, Jaana Rautava, Kari Syrjänen, Seija Grenman, Stina Syrjänen. Oral mucosa as a reservoir of human papillomavirus: . point prevalence, genotype
distribution, and incident infections among males in a 7-year prospective study. Eur Urol 2012;62:1063-70.
|
|
19 |
Kersten C et al. |
Increased C-reactive protein implies a poorer stage-specific prognosis in colon cancer.
|
|
20 |
Knuuti J et al. |
Is cardiac magnetic resonance imaging causing DNA damage?
|
|
21 |
Korkeila E. |
Feed Back.
|
|
22 |
Koskela H et al. |
Disease outcome of patients with pancreatic cancer in a cohort treated outside clinicla trials .
|
|
23 |
Koskimies P et al. |
Oral bioavailability of ospemifene improves with food intake.
|
|
24 |
Kähkönen E et al. |
In Vivo imaging of prostate cancer using (68Ga)-labeled bombesin analog BAY86-7548.
|
|
25 |
Lindholm P, Kivioja A. |
Luusarkooma.
|
|
26 |
Louvanto K et al. |
Genotype-specific incidence and clearance of human papillomavirus in oral mucosa of women: A six-year follow-up study.
|
|
27 |
Monsonego J et al. |
Prevalence of genotype-specific HPV infection among women in France: Implications for screening and vaccination (in French).
|
|
28 |
Närvä E et al. |
Continuous hypoxic culturing of human embryonic stem cells enhances SSEA-3 and MYC levels.
|
|
29 |
Rantanen K et al. |
p62/SQSTM1 regulates cellular oxygen sensing by attenuating PHD3 activity through aggregate sequestration and enhanced degradation.
|
|
30 |
Ristamäki R. |
Endokriiniset syövät.
|
|
31 |
Roberts PJ et al. |
Mahasyöpä.
|
|
32 |
Roberts PJ et al. |
Maksan ja sappiteiden syöpä.
|
|
33 |
Roivainen A et al. |
Plasma pharmacokinetics, whole-body distribution metabolism, and radiation dosimetry of 68ga bombesin antagonist BAY 86-7548 in healthy men.
|
|
34 |
Salminen E. |
Ympäristöherkkyys- taistelu tuulimyllyjä vastaan?
|
|
35 |
Salminen EK et al. |
Opioids in pain management of mesothelioma and lung cancer patients.
|
|
36 |
Salminen P, Ristamäki R. |
Leikkauskelpoisen mahasyövän perioperatiivinen solunsalpaajahoito - näyttöön perustuvasta hoidosta kliiniseksi käytännöksi.
|
|
37 |
Salomaa S et al. |
State of the art in research into the risk of low dose radiation exposure-findings of the fourth MELODI workshop.
|
|
38 |
Suominen E. et al. |
Ihosyövän yleisyys ja vaaratekijät.
|
|
39 |
Syrjänen K. |
Geographic origin is a significant determinant of human papillomavirus prevalence in oesophageal squamous cell carcinoma: Systematic review and meta-analysis.
|
|
40 |
Syrjänen K. |
Suomalainen FIT-testi: Entistä tehokkaampaa suolistosyövän seulontaa.
|
|
41 |
Syrjänen K. |
Yksinkertainen testi paljastaa onko mahalaukku terve.
|
|
42 |
Syrjänen K. |
Keynotes from the new editor-in-chief.
|
|
43 |
Syrjänen K, Syrjänen S. |
Detection of human papillomavirus in sinonasal carcinoma: systematic review and meta-analysis.
|
|
44 |
Syrjänen K, Syrjänen S. |
Detection of human papillomavirus in esophageal papillomas: systematic review and meta-analysis.
|
|
45 |
Syrjänen K, Syrjänen S. |
Detection of human papillomavirus in sinonasal papillomas:systematic review and meta-analysis.
|
|
46 |
Syrjänen K, Syrjänen S. |
Solitary bronchial squamous cell papilloma - another human papillomavirus (HPV)-associated benign tumor: systematic review and meta-analysis.
|
|
47 |
Syrjänen S et al. |
Competing-risks regression models in analysis of biomarkers as predictors of high-risk human papillomavirus (HPV) infection outcomes and incident CIN in the LAMS cohort.
|
|
48 |
Ylönen O et al. |
Kivessyövän hoito ja seuranta räätälöidään riskiluokituksen mukaan .
|